疫苗有效率不能仅仅解读数字,不同疫苗测试时间不一样,感染率也不一样。

billwanhua

资深人士
注册
2005-07-07
消息
2,864
荣誉分数
742
声望点数
273

“Timing is critical too. The Moderna and Pfizer/BioNTech studies finished enrolling participants in their phase 3 trials in October and reported their results in late November. The Johnson & Johnson phase 3 trial only finished enrolling participants in December 2020 and reported their results in January.

That means the Johnson & Johnson vaccine was tested during one of the most severe stages of the pandemic, when transmission, cases, and hospitalizations were at their worst in many places around the world, including the US. The trial also captured efficacy against the new variants of SARS-CoV-2 (the virus that causes Covid-19) which began circulating at this point in some parts of the world. Several of these variants have shown themselves to be more contagious, deadlier, and more likely to evade protection from vaccines and prior immunity.”

But when Johnson & Johnson filed for an emergency use authorization from the Food and Drug Administration for its Covid-19 vaccine in early February, it reported that its overall efficacy in preventing Covid-19 cases that produced symptoms was 66.1 percent. The Moderna vaccine and the Pfizer/BioNTech vaccines reported efficacy levels around 95 percent.
In addition, health officials have been emphasizing that the most important numbers — how well the vaccines prevent hospitalizations and deaths — are consistent across the board and are arguably more comparable. Even after these vaccines have begun distribution, researchers are finding that Covid-19 vaccines are doing a remarkable job of keeping people alive.
That’s why the recommendation remains that the best Covid-19 vaccine for the vast majority of people is the first one they can get. “That’s how I think of these vaccines, as basically interchangeable,” said Adalja.
 

向问天

日月神教光明左使
VIP
注册
2012-09-04
消息
59,388
荣誉分数
10,775
声望点数
1,273

“Timing is critical too. The Moderna and Pfizer/BioNTech studies finished enrolling participants in their phase 3 trials in October and reported their results in late November. The Johnson & Johnson phase 3 trial only finished enrolling participants in December 2020 and reported their results in January.

That means the Johnson & Johnson vaccine was tested during one of the most severe stages of the pandemic, when transmission, cases, and hospitalizations were at their worst in many places around the world, including the US. The trial also captured efficacy against the new variants of SARS-CoV-2 (the virus that causes Covid-19) which began circulating at this point in some parts of the world. Several of these variants have shown themselves to be more contagious, deadlier, and more likely to evade protection from vaccines and prior immunity.”

But when Johnson & Johnson filed for an emergency use authorization from the Food and Drug Administration for its Covid-19 vaccine in early February, it reported that its overall efficacy in preventing Covid-19 cases that produced symptoms was 66.1 percent. The Moderna vaccine and the Pfizer/BioNTech vaccines reported efficacy levels around 95 percent.
In addition, health officials have been emphasizing that the most important numbers — how well the vaccines prevent hospitalizations and deaths — are consistent across the board and are arguably more comparable. Even after these vaccines have begun distribution, researchers are finding that Covid-19 vaccines are doing a remarkable job of keeping people alive.
That’s why the recommendation remains that the best Covid-19 vaccine for the vast majority of people is the first one they can get. “That’s how I think of these vaccines, as basically interchangeable,” said Adalja.


就是。
不同时间段得出的有效率没有可比性。
 

贵圈

https://bbs.comefromchina.com/threads/1733668/
注册
2014-10-21
消息
13,870
荣誉分数
2,706
声望点数
273

贵圈

https://bbs.comefromchina.com/threads/1733668/
注册
2014-10-21
消息
13,870
荣誉分数
2,706
声望点数
273
但是透明度是可以比较的。
 

billwanhua

资深人士
注册
2005-07-07
消息
2,864
荣誉分数
742
声望点数
273
这上面说Johnson在南非和巴西测试。如果我们能够看到Johnson疫苗在巴西和南非的单独数据,就更好了。
Johnson把所有地方的实验数据放一起66%,为什么Sinovac不能把所有实验放一起公布呢?
好像视频上说了南非实验数据是64%
 

向问天

日月神教光明左使
VIP
注册
2012-09-04
消息
59,388
荣誉分数
10,775
声望点数
1,273
这上面说Johnson在南非和巴西测试。如果我们能够看到Johnson疫苗在巴西和南非的单独数据,就更好了。
Johnson把所有地方的实验数据放一起66%,为什么Sinovac不把所有实验放一起公布呢?
好像视频上说了南非实验数据是64%


是啊,为什么西方报道Sinovac一般提最低那个数字?


另外,阿斯利康,实验中第一针只用半剂的那个效率高,但是实用的时候为什么不用半剂的?
 
顶部